Cargando…
Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model
Cebranopadol (trans‐6′‐fluoro‐4′,9′‐dihydro‐N,N‐dimethyl‐4‐phenyl‐spiro[cyclohexane‐1,1′(3′H)‐pyrano[3,4‐b]indol]‐4‐amine) is a novel analgesic nociceptin/orphanin FQ opioid peptide (NOP) and classical opioid receptor (MOP, DOP, and KOP) agonist with highly efficacious and potent activity in a broad...
Autores principales: | Christoph, Thomas, Raffa, Robert, De Vry, Jean, Schröder, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262002/ https://www.ncbi.nlm.nih.gov/pubmed/30519474 http://dx.doi.org/10.1002/prp2.444 |
Ejemplares similares
-
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
por: Rizzi, Anna, et al.
Publicado: (2016) -
Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
por: Sałat, Kinga, et al.
Publicado: (2017) -
Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists
por: Park, Jong Yung, et al.
Publicado: (2019) -
Regulating and regulated role of the orphanin FQ/nociceptin system
por: Tekes, Kornélia, et al.
Publicado: (2009) -
Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain
por: El Daibani, Amal, et al.
Publicado: (2022)